188Re-labeled degradable nano-probe for breast cancer diagnosis and treatment and preparation method thereof
A nanoprobe, 188re technology, applied in the field of tumor treatment, can solve the problem of not significantly prolonging the survival time of patients
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] 188 Re-labeled degradable nanoprobes for breast cancer diagnosis and treatment. The nanoprobes are composed of PLGA nanoparticles loaded with IDO inhibitors. The nanoprobes include the following components according to the molar mass: lactide 4mol, glycolide 1mol, octanoic acid stannous, surfactant PIC-PEO, IDO inhibitor and dispersant PEG, the nanoprobe is linked with folic acid for targeting 4T1 breast cancer, and linked with 188 Re is used for targeted tracking of breast cancer and lymph node metastasis, SPECT imaging and internal radiation sensitization therapy.
[0026] The preparation method is as follows: S1) mixing lactide and glycolide, adding an initiator, melting and ring-opening polymerization under vacuum conditions to obtain PLGA; S2) dissolving PLGA and surfactant in IDO inhibitor, adding Dispersant, by controlling the microfluidic extrusion speed to make nanoprobes; S3) connecting folic acid on the nanoprobes;
[0027] S4) connection on the nanoprobe ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com